4.6 Article

Dissecting the Within-Africa Ancestry of Populations of African Descent in the Americas

期刊

PLOS ONE
卷 6, 期 1, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0014495

关键词

-

资金

  1. Public Health Service [R29-ES08031, R01-CA85074, P50-CA105641]

向作者/读者索取更多资源

Background: The ancestry of African-descended Americans is known to be drawn from three distinct populations: African, European, and Native American. While many studies consider this continental admixture, few account for the genetically distinct sources of ancestry within Africa - the continent with the highest genetic variation. Here, we dissect the within-Africa genetic ancestry of various populations of the Americas self-identified as having primarily African ancestry using uniparentally inherited mitochondrial DNA. Methods and Principal Findings: We first confirmed that our results obtained using uniparentally-derived group admixture estimates are correlated with the average autosomal-derived individual admixture estimates (hence are relevant to genomic ancestry) by assessing continental admixture using both types of markers (mtDNA and Y-chromosome vs. ancestry informative markers). We then focused on the within-Africa maternal ancestry, mining our comprehensive database of published mtDNA variation (similar to 5800 individuals from 143 African populations) that helped us thoroughly dissect the African mtDNA pool. Using this well-defined African mtDNA variation, we quantified the relative contributions of maternal genetic ancestry from multiple W/WC/SW/SE (West to South East) African populations to the different pools of today's African-descended Americans of North and South America and the Caribbean. Conclusions: Our analysis revealed that both continental admixture and within-Africa admixture may be critical to achieving an adequate understanding of the ancestry of African-descended Americans. While continental ancestry reflects gender-specific admixture processes influenced by different socio-historical practices in the Americas, the within-Africa maternal ancestry reflects the diverse colonial histories of the slave trade. We have confirmed that there is a genetic thread connecting Africa and the Americas, where each colonial system supplied their colonies in the Americas with slaves from African colonies they controlled or that were available for them at the time. This historical connection is reflected in different relative contributions from populations of W/WC/SW/SE Africa to geographically distinct Africa-derived populations of the Americas, adding to the complexity of genomic ancestry in groups ostensibly united by the same demographic label.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Influence of county-level geographic/ancestral origin on glioma incidence and outcomes in US Hispanics

Kyle M. Walsh, Corey Neff, Melissa L. Bondy, Carol Kruchko, Jason T. Huse, Christopher Amos, Jill S. Barnholtz-Sloan, Quinn T. Ostrom

Summary: The incidence and outcomes of glioma differ in association with the geographic origins of Hispanic communities, with predominantly Mexican/Central American-origin counties at reduced risk and predominantly Caribbean-origin counties at greater risk. Higher incidence and improved survival are associated with European admixture in Hispanic patients.

NEURO-ONCOLOGY (2023)

Article Oncology

Exposure to radon and heavy particulate pollution and incidence of brain tumors

Joshua D. Palmer, Rahul N. Prasad, Gino Cioffi, Carol Kruchtko, Nicholas G. Zaorsky, Daniel M. Trifiletti, Vinai Gondi, Paul D. Brown, Haley K. Perlow, Mark Mishra, Arnab Chakravarti, Jill S. Barnholtz-Sloan, Quinn T. Ostrom

Summary: This study suggests a potential association between exposure to high levels of particulate pollution and radon and increased incidence of non-malignant brain tumors. However, more research is needed to confirm these findings in other populations.

NEURO-ONCOLOGY (2023)

Article Oncology

National-level overall survival patterns for molecularly-defined diffuse glioma types in the United States

Quinn T. Ostrom, Madison L. Shoaf, Gino Cioffi, Kristin Waite, Carol Kruchko, Patrick Y. Wen, Daniel J. Brat, Jill S. Barnholtz-Sloan, J. Bryan Iorgulescu

Summary: This study utilized data from the U.S. National Cancer Database to estimate the national-level overall survival patterns of molecularly-defined diffuse gliomas. The findings demonstrate differences in survival rates among different glioma types, and the impact of WHO grade and MGMT promoter methylation on survival.

NEURO-ONCOLOGY (2023)

Article Clinical Neurology

Molecular marker testing and reporting completeness for adult-type diffuse gliomas in the United States

Corey Neff, Gino Cioffi, Kristin Waite, Carol Kruchko, Jill S. Barnholtz-Sloan, Quinn T. Ostrom, J. Bryan Iorgulescu

Summary: This study investigated the testing and reporting completeness of a newly developed brain molecular marker (BMM) in the US. The overall completeness was 81.1%, with variations among different subgroups and hospital attributes.

NEURO-ONCOLOGY PRACTICE (2023)

Letter Immunology

Cancer risk among HIV-exposed uninfected children in the United States

Marie-Josephe Horner, Rohan Hazra, Jill S. Barnholtz-Sloan, Meredith S. Shiels, Eric A. Engels

Summary: In utero exposure to didanosine was associated with increased risk of brain cancer in a French study. We used United States health department records to assess cancer risk among 13,617 children exposed to HIV in utero, who remained HIV-uninfected after birth (1990-2017). Risk of brain tumors was borderline elevated among these children (standardized incidence ratio 2.2, 95% confidence interval 0.8-4.8, P=0.12, based on six cases). Risk was not significantly increased for leukemia or other cancers.
Editorial Material Oncology

Expanding our knowledge of brain tumor overall survival trends at a global scale

Jill S. Barnholtz-Sloan

NEURO-ONCOLOGY (2023)

Article Multidisciplinary Sciences

Racial disparities in breast cancer treatment patterns and treatment related adverse events

Nickolas Stabellini, Jennifer Cullen, Lifen Cao, John Shanahan, Nelson Hamerschlak, Kristin Waite, Jill S. Barnholtz-Sloan, Alberto J. Montero

Summary: The study aimed to analyze the differences in treatment patterns and treatment related adverse events in Non-Hispanic women with breast cancer based on race. The results showed that Non-Hispanic Black women were less likely to undergo surgery or receive endocrine therapy, but more likely to receive radiotherapy. They also had a higher risk of cognitive decline/dementia after treatment.

SCIENTIFIC REPORTS (2023)

Article Oncology

Sex differences in adults with acute myeloid leukemia and the impact of sex on overall survival

Nickolas Stabellini, Benjamin Tomlinson, Jennifer Cullen, John Shanahan, Kristin Waite, Alberto J. J. Montero, Jill S. S. Barnholtz-Sloan, Nelson Hamerschlak

Summary: This study conducted a comprehensive analysis of sex differences in acute myeloid leukemia (AML) and found that there are disparities in incidence and survival between males and females. Treatment and healthcare factors have important implications for survival rates.

CANCER MEDICINE (2023)

Article Oncology

Genetic Factors Associated with Absolute and Relative Plasma Concentrations of Calcitriol

Robin Taylor Wilson, Susan E. Safford, Quinn T. Ostrom, Ming Wang, Alicia C. McDonald, Anna C. Salzberg, Jill S. Barnholtz-Sloan, John P. Richie

Summary: In this cross-sectional study, little is known regarding factors associated with calcitriol and the calcitriol-24,25-dihydroxyvitamin D3-calcifediol proportion ratio (C24CPR). The study found that calcitriol and C24CPR were both significantly, positively, and monotonically associated with West African genetic ancestry proportion (WGA). These findings suggest that C24CPR may be more suitable for personalized medicine.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2023)

Article Oncology

Mortality trends in primary malignant brain and central nervous system tumors vary by histopathology, age, race, and sex

Marisa Thierheimer, Gino Cioffi, Kristin A. A. Waite, Carol Kruchko, Quinn T. T. Ostrom, Jill S. S. Barnholtz-Sloan

Summary: This study examined mortality trends for primary malignant brain and other central nervous system tumors in the United States. The overall mortality rate showed a slight increase from 2004 to 2018, with the highest increase observed in Asian/Pacific Islander or American Indian/Alaskan Native populations. Age-specific mortality rates varied among different histopathology groupings, with glioblastoma showing a small increase in adults > 65 years old and other malignant gliomas declining in the same age group. Examining these trends can provide important information for clinicians, researchers, and public health planning.

JOURNAL OF NEURO-ONCOLOGY (2023)

Article Oncology

The association of Medicaid expansion and pediatric cancer overall survival

Justin M. Barnes, Corey Neff, Xuesong Han, Carol Kruchko, Jill S. Barnholtz-Sloan, Quinn T. Ostrom, Kimberly J. Johnson

Summary: Medicaid expansion is associated with improved access to care in children with cancer and a 1.50 percentage point increase in 2-year overall survival after 2014 in expansion states compared to nonexpansion states. The impact is particularly significant for children living in the lowest county income quartile, with a 5.12 percentage point increase in survival.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Article Oncology

Brain tumors in United States military veterans

John R. Bihn, Gino Cioffi, Kristin A. Waite, Carol Kruchko, Corey Neff, Mackenzie Price, Quinn T. Ostrom, Kaitlin N. Swinnerton, Danne C. Elbers, Michael A. Mooney, Jacob Rachlin, Thor D. Stein, Mary T. Brophy, Nhan Do, Ryan E. Ferguson, David S. Priemer, Daniel P. Perl, Richard A. Hickman, Burt Nabors, Jennifer Rusiecki, Jill S. Barnholtz-Sloan, Nathanael R. Fillmore

Summary: This study provides comprehensive analysis of brain tumor incidence and survival in the Veteran population, revealing differences in comparison to the overall US population. Nonmalignant tumors are more common among Veterans, and survival outcomes worsen with age.

NEURO-ONCOLOGY (2023)

Article Oncology

Critical Partnerships: How to Develop a Trans-Disciplinary Research Team

Kristin A. Waite, Peter J. Pronovost, Jill S. Barnholtz-Sloan

Summary: Trans-disciplinary science is crucial for understanding cancer development, progression, and treatment. Transitioning from an independent researcher to a leader or productive member of a scientific team requires focusing on key elements such as team selection, communication, leadership, shared goals, team responsibility, authorship, and conflict resolution.

CANCERS (2023)

Article Clinical Neurology

Childhood, adolescent, and adult primary brain and central nervous system tumor statistics for practicing healthcare providers in neuro-oncology, CBTRUS 2015-2019

Mackenzie Price, Katherine Ryan, Madison L. Shoaf, Corey Neff, J. Bryan Iorgulescu, Daniel B. Landi, Gino Cioffi, Kristin A. Waite, Carol Kruchko, Jill S. Barnholtz-Sloan, Quinn T. Ostrom

Summary: This report summarizes the latest population-based incidence, mortality, and survival data for primary brain and other CNS tumors in the US, aiming to serve as a concise resource for neuro-oncology providers.

NEURO-ONCOLOGY PRACTICE (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Novel 3D magnetic resonance fingerprinting radiomics in adult brain tumors: a feasibility study

Charit Tippareddy, Louisa Onyewadume, Andrew E. Sloan, Gi-Ming Wang, Nirav T. Patil, Siyuan Hu, Jill S. Barnholtz-Sloan, Rasim Boyacioglu, Vikas Gulani, Jeffrey Sunshine, Mark Griswold, Dan Ma, Chaitra Badve

Summary: This study aimed to test the feasibility of using 3D MRF maps with radiomics analysis and machine learning in the characterization of adult brain intra-axial neoplasms. The results showed that MRF maps were able to differentiate tumors based on type, grade, and IDH1 status. Furthermore, the radiomics features of MRF maps can also characterize gliomas based on grade, IDH1 status, and survival.

EUROPEAN RADIOLOGY (2023)

暂无数据